Polymorphisms in the Vitamin D System and Health
1 other identifier
observational
9,700
1 country
1
Brief Summary
Polymorphisms in the vitamin D system appear to affect the serum 25(OH)D levels. If so one would expect these polymorphisms to be associated with vitamin D related conditions and diseases, which will be tested in the present study including DNA analyses in 9700 subjects
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Apr 2011
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2011
CompletedFirst Submitted
Initial submission to the registry
July 14, 2011
CompletedFirst Posted
Study publicly available on registry
July 15, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2016
CompletedNovember 11, 2016
November 1, 2016
5.3 years
July 14, 2011
November 10, 2016
Conditions
Keywords
Study Arms (8)
myocardial infarction
subjects with myocardial infarction in the Tromsø study end point registry
type 2 diabetes
subjects with type 2 diabetes in the Tromsø study end point registry
stroke
subjects with stroke in the Tromsø study end point registry
fracture
subjects with fracture in the Tromsø study end point registry
cancer
subjects with cancer in the Tromsø study end point registry
death
subjects registered as dead in the Tromsø study end point registry
aortic stenosis
subjects with aortic stenosis in the Tromsø study end point registry
control group
randomly selected controls from the Tromsø study
Eligibility Criteria
Subjects from the fourth Tromsø study performed in 1994-1995 who had blood samples taken for later DNA analyses
You may qualify if:
- participated in the fourth Tromsø study, later registered in our end point registry or selected as a control subject
You may not qualify if:
- lacking DNA sample
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Tromsø
Tromsø, Tromsø, 9037, Norway
Related Publications (1)
Jorde R, Schirmer H, Wilsgaard T, Joakimsen RM, Mathiesen EB, Njolstad I, Lochen ML, Figenschau Y, Berg JP, Svartberg J, Grimnes G. Polymorphisms related to the serum 25-hydroxyvitamin D level and risk of myocardial infarction, diabetes, cancer and mortality. The Tromso Study. PLoS One. 2012;7(5):e37295. doi: 10.1371/journal.pone.0037295. Epub 2012 May 23.
PMID: 22649517DERIVED
Biospecimen
DNA from blood clots
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Rolf Jorde, Professor
University of Tromso
Study Design
- Study Type
- observational
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
July 14, 2011
First Posted
July 15, 2011
Study Start
April 1, 2011
Primary Completion
July 1, 2016
Study Completion
August 1, 2016
Last Updated
November 11, 2016
Record last verified: 2016-11